基因富集分析HER2基因对胃癌免疫微环境的影响
An Analysis of the Effect of HER2 Gene on the Immune Microenvironment of Gastric Cancer by Gene Enrichment Analysis
DOI: 10.12677/ACM.2024.142419, PDF,   
作者: 赵佳宇, 荆瑶瑶：青岛大学医学院，山东 青岛；刘自民*：青岛大学附属医院消化肿瘤诊疗中心，山东 青岛
关键词: 人表皮生长因子受体2；胃癌；免疫微环境；富集分析；Human Epidermal Growth Factor Receptor-2； Gastric Cancer； Immune Microenvironment； Enrichment Analysis
摘要: 目的：运用基因富集分析探索HER2基因表达状态对胃癌生物学功能和代谢通路的影响，并进一步探讨其对胃癌免疫微环境的影响。方法：下载癌症基因组图谱(TCGA)数据库的胃癌转录组数据，根据HER2 mRNA表达水平分为高低表达组、应用R语言和GSEA软件进行富集分析。结果：GO富集分析表明，HER2基因高低表达组的差异基因主要参与骨化、细胞外基质组织、胶原纤维组织、结缔组织发育等过程；KEGG分析富集的信号通路主要为PI3K-AKT信号通路、黏着斑信号通路、刺激神经组织的配体–受体互作通路；GSEA软件分析HER2高表达组mTOR信号通路、Notch信号通路、磷酸戊糖途径信号通路、神经营养素信号通路等表达上调。结论：细胞外基质状态、PI3K-AKT信号通路、黏着斑信号通路、mTOR信号通路、Notch信号通路可能与HER2阳性胃癌侵袭性强、免疫治疗明显获益相关。
Abstract: Objective: To investigate the effect of HER2 gene expression on the biological function and metabol-ic pathways of gastric cancer by gene enrichment analysis, and further explore its effect on the im-mune microenvironment of gastric cancer. Methods: The transcriptome data of gastric cancer from The Cancer Genome Atlas (TCGA) database were downloaded and divided into high and low expres-sion groups according to the expression level of HER2 mRNA. Enrichment analysis was performed using R language and GSEA software. Results: GO enrichment analysis showed that the differentially expressed HER2 genes in high and low expression groups were mainly involved in ossification, and development of extracellular matrix tissue, collagen fiber tissue and connective tissue. KEGG analy-sis showed that the enriched signaling pathways were mainly PI3K-AKT signaling pathway, adhe-sion plaque signaling pathway and ligand-receptor interaction pathway that stimulated nerve tis-sue. GSEA software analysis showed that the expression of aminoacyl tRNA signaling pathway, mTOR signaling pathway, Notch signaling pathway, pentose phosphate signaling pathway and neu-rotrophic signaling pathway in HER2 high expression group was up-regulated. Conclusion: The ex-tracellular matrix status, PI3K-AKT signaling pathway, adhesion plaque signaling pathway, mTOR signaling pathway, Notch signaling pathway may be associated with strong invasiveness and signif-icant efficacy of immunotherapy in HER2-positive gastric cancer.
文章引用：赵佳宇, 荆瑶瑶, 刘自民. 基因富集分析HER2基因对胃癌免疫微环境的影响[J]. 临床医学进展, 2024, 14(2): 2959-2965. https://doi.org/10.12677/ACM.2024.142419

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Van Cutsem, E., Bang, Y.J., Feng-Yi, F., et al. (2015) HER2 Screening Data from ToGA: Targeting HER2 in Gastric and Gastroesophageal Junction Cancer. Gastric Cancer, 18, 476-484. [Google Scholar] [CrossRef] [PubMed]
[3] Janjigian, Y.Y., Kawazoe, A., Bai, Y., et al. (2023) Pembroli-zumab Plus Trastuzumab and Chemotherapy for HER2- Positive Gastric or Gastro-Oesophageal Junction Adenocarci-noma: Interim Analyses from the Phase 3 KEYNOTE-811 Randomised Placebo-Controlled Trial. The Lancet, 402, 2197-2208. [Google Scholar] [CrossRef] 
[4] He, Y., Liu, T., Dai, S., et al. (2021) Tu-mor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-Tumor Immunotherapy? Frontiers in Cell and Developmental Biology, 9, Article ID: 739161. [Google Scholar] [CrossRef] [PubMed]
[5] Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K.J., et al. (2020) Concepts of Extracellular Matrix Remodelling in Tumour Progression and Metastasis. Nature Communications, 11, 5120. [Google Scholar] [CrossRef] [PubMed]
[6] Mohan, V., Das, A. and Sagi, I. (2020) Emerging Roles of ECM Remodeling Processes in Cancer. Seminars in Cancer Biology, 62, 192-200. [Google Scholar] [CrossRef] [PubMed]
[7] Gao, S., Yang, D., Fang, Y., et al. (2019) Engineering Na-noparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy. Theranostics, 9, 126-151. [Google Scholar] [CrossRef] [PubMed]
[8] Sutherland, T.E., Dyer, D.P. and Allen, J.E. (2023) The Ex-tracellular Matrix and the Immune System: A Mutually Dependent Relationship. Science, 379, abp8964. [Google Scholar] [CrossRef] [PubMed]
[9] Jurmeister, P., Von Laffert, M. and Johrens, K. (2020) Dissecting the Spatial Heterogeneity of Different Immune Cell Subsets in Non-Small Cell Lung Cancer. Pathology - Research and Practice, 216, Article ID: 152904. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, B., Liu, D.A., Guan, L., et al. (2023) Stiff Matrix Induces Exosome Secretion to Promote Tumour Growth. Nature Cell Biology, 25, 415-424. [Google Scholar] [CrossRef] [PubMed]
[11] Suh, K.J., Sung, J.H., Kim, J.W., et al. (2017) EGFR or HER2 Inhibition Modulates the Tumor Microenvironment by Suppression of PD-L1 and Cytokines Release. Oncotarget, 8, 63901-63910. [Google Scholar] [CrossRef] [PubMed]
[12] Lei, Z.N., Teng, Q.X., Tian, Q., et al. (2022) Sig-naling pathways and Therapeutic Interventions in Gastric Cancer. Signal Transduction and Targeted Therapy, 7, 358. [Google Scholar] [CrossRef] [PubMed]
[13] Fiedler, M., Schulz, D., Piendl, G., et al. (2020) Buparlisib Modulates PD-L1 Expression in Head and Neck Squamous Cell Carcinoma Cell Lines. Experimental Cell Research, 396, Article ID: 112259. [Google Scholar] [CrossRef] [PubMed]
[14] Ni, J.M. and Ni, A.P. (2018) Landscape of PD-1/PD-L1 Regu-lation and Targeted Immunotherapy. Chinese Medical Sciences Journal, 33, 174-182.
[15] Zerdes, I., Matikas, A., Bergh, J., et al. (2018) Genetic, Transcriptional and Post-Translational Regulation of the Programmed Death Protein Ligand 1 in Cancer: Biology and Clinical Correlations. Oncogene, 37, 4639-4661. [Google Scholar] [CrossRef] [PubMed]
[16] Sukumar, M., Liu, J., Ji, Y., et al. (2013) Inhibiting Glycolytic Metabolism Enhances CD8+ T Cell Memory and Antitumor Function. Journal of Clinical Investigation, 123, 4479-4488. [Google Scholar] [CrossRef] 
[17] Daneshmandi, S., Cassel, T., Lin, P., et al. (2021) Blockade of 6-Phosphogluconate Dehydrogenase Generates CD8(+) Effector T Cells with Enhanced Anti-Tumor Function. Cell Re-ports, 34, Article ID: 108831. [Google Scholar] [CrossRef] [PubMed]
[18] Klein Geltink, R.I., Edwards-Hicks, J., Apostolova, P., et al. (2020) Metabolic Conditioning of CD8(+) Effector T Cells for Adoptive Cell Therapy. Nature Metabolism, 2, 703-716. [Google Scholar] [CrossRef] [PubMed]
[19] Feng, Q., Song, D. and Wang, X. (2021) Pan-Cancer Analysis Reveals that Neurotrophin Signaling Correlates Positively with Anti-Tumor Immunity, Clinical Outcomes, and Response to Targeted Therapies and Immunotherapies in Cancer. Life Sciences, 282, Article ID: 119848. [Google Scholar] [CrossRef] [PubMed]

为你推荐